Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Type of study
Publication year range
1.
Neuroscience ; 109(3): 609-17, 2002.
Article in English | MEDLINE | ID: mdl-11823070

ABSTRACT

The mechanism of action of conventional antidepressants (e.g. imipramine) has been linked to modulation of central monoamine systems. Substance P (NK1) receptor antagonists may have antidepressant and anxiolytic effects in patients with major depressive disorder and high anxiety but, unlike conventional antidepressants, are independent of activity at monoamine reuptake sites, transporters, receptors, or monoamine oxidase. To investigate the possibility that substance P receptor antagonists influence central monoamine systems indirectly, we have compared the effects of chronic administration of imipramine with that of the substance P receptor antagonist L-760735 on the spontaneous firing activity of locus coeruleus neurones. Electrophysiological recordings were made from brain slices prepared from guinea-pigs that had been dosed orally every day for 4 weeks with either L-760735 (3 mg/kg), imipramine (10 mg/kg), or vehicle (water), or naive animals. Chronic, but not acute, treatment with the substance P receptor antagonist L-760735, induced burst firing of neurones in the locus coeruleus. This effect resembles that of the conventional antidepressant imipramine. However, their effects are dissociable since, in contrast to chronic imipramine treatment, chronic L-760735 treatment does not cause functional desensitisation of somatic alpha2 adrenoceptors. The mechanism by which chronic substance P receptor antagonist or conventional antidepressant treatment influences the pattern of firing activity of norepinephrine neurones remains to be elucidated. However, an indirect action in the periphery or distant brain nuclei has been excluded by the use of the in vitro slice preparation, suggesting a local site of action in the locus coeruleus.


Subject(s)
Action Potentials/drug effects , Anti-Anxiety Agents/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Locus Coeruleus/drug effects , Morpholines/pharmacology , Neurokinin-1 Receptor Antagonists , Neurons/drug effects , Norepinephrine/metabolism , Action Potentials/physiology , Adrenergic alpha-2 Receptor Agonists , Adrenergic alpha-2 Receptor Antagonists , Animals , Animals, Newborn , Drug Administration Schedule , Guinea Pigs , Locus Coeruleus/metabolism , Male , Neurons/metabolism , Receptors, Adrenergic, alpha-2/metabolism , Receptors, Neurokinin-1/agonists , Receptors, Neurokinin-1/metabolism
2.
Br J Pharmacol ; 133(6): 807-14, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11454653

ABSTRACT

Migraine headache is thought to be caused by a distension of meningeal blood vessels, the activation of trigeminal sensory neurones and the the development of a central sensitization within the trigeminal nucleus caudalis (TNC). It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC. Since opioids are also effective anti-migraine agents the present studies investigated the role of opioids within the trigemino-vascular system in anaesthetised rats. Electrical stimulation of the dura mater evoked neurogenic dural vasodilation which was significantly inhibited by morphine (1 mg kg(-1)) the selective mu-opioid agonist DAGO (10 microg kg(-1)) and the mixed agonist/antagonist butorphanol (1 mg kg(-1)) but not by the kappa- and delta-opioid agonists (+/-) U50488H (100 microg kg(-1)) and DPDPE (1 mg kg(-1)). Morphine had no effect on CGRP-evoked dural vasodilation. In electrophysiological studies morphine (1 - 10 mg kg(-1)) significantly attenuated brainstem neuronal activity in response to electrical stimulation of the dura by 65% at 10 mg kg(-1). Morphine (3 mg kg(-1)) also inhibited the TNC neuronal sensitization following CGRP-evoked dilation. The present studies have demonstrated that opioids block the nociceptive neurotransmission within the trigeminal nucleus caudalis and in addition inhibit neurogenic dural vasodilation via an action on mu-opioid receptors located on trigeminal sensory fibres innervating dural blood vessels. These peripheral and central actions are similar to those of the 'triptan' 5-HT(1B/1D) agonists and could account for the anti-migraine actions of opioids.


Subject(s)
Dura Mater/physiology , Neurons/physiology , Receptors, Opioid/physiology , Trigeminal Caudal Nucleus/physiology , Vasodilation/physiology , 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology , Action Potentials/drug effects , Analgesics, Non-Narcotic/pharmacology , Analgesics, Opioid/pharmacology , Anesthesia , Animals , Blood Vessels/drug effects , Blood Vessels/physiology , Butorphanol/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Dose-Response Relationship, Drug , Dura Mater/blood supply , Dura Mater/drug effects , Electric Stimulation , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Enkephalin, D-Penicillamine (2,5)-/pharmacology , Male , Morphine/pharmacology , Neurons/drug effects , Rats , Rats, Sprague-Dawley , Trigeminal Caudal Nucleus/cytology , Trigeminal Caudal Nucleus/drug effects , Vasodilation/drug effects
3.
Br J Pharmacol ; 126(6): 1478-86, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10217543

ABSTRACT

1. Migraine headache pain is thought to result from an abnormal distention of intracranial, extracerebral blood vessels and the consequent activation of the trigeminal nervous system. Migraine is also often accompanied by extracranial sensory disturbances from facial tissues. These experiments investigate whether meningeal dilation produces central sensitization of neurones that receive convergent input from the face. 2. Single unit extracellular activity was recorded from the trigeminal nucleus caudalis of anaesthetized rats in response to either noxious stimulation of the dura mater, innocuous stimulation of the vibrissae or to a transient dilation of the meningeal vascular bed. 3. Rat alpha-CGRP (calcitonin gene-related peptide; 1 microg kg(-1), i.v.) caused a dilation of the middle meningeal artery and facilitated vibrissal responses by 36+/-7%. 4. The 5-HT1B/1D agonist, L-741,604 (3 mg kg(-1), i.v.), inhibited responses to noxious stimulation of the dura mater (16+/-7% of control) and, in a separate group of animals, blocked the CGRP-evoked facilitation of vibrissal responses. 5. L-741,604 (3 mg kg(-1), i.v.) also inhibited responses to innocuous stimulation of the vibrissa (14+/-10% of control) with neurones that received convergent input from the face and from the dura mater, but not with cells that received input only from the face (70+/-12% of control). 6. These data show that dilation of meningeal blood vessels causes a sensitization of central trigeminal neurones and a facilitation of facial sensory processing which was blocked by activation of pre-synaptic 5-HT1B/1D receptors. 7. Sustained dural blood vessel dilation during migraine may cause a sensitization of trigeminal neurones. This may underlie some of the symptoms of migraine, such as the headache pain and the extracranial allodynia. Inhibition of this central sensitization may therefore offer a novel strategy for the development of acute and/or prophylactic anti-migraine therapies.


Subject(s)
Dura Mater/drug effects , Neurons/drug effects , Serotonin Receptor Agonists/pharmacology , Trigeminal Nuclei/drug effects , Vasodilation/drug effects , Action Potentials/drug effects , Animals , Calcitonin Gene-Related Peptide/pharmacology , Dose-Response Relationship, Drug , Dura Mater/physiology , Male , Meningeal Arteries/drug effects , Meningeal Arteries/physiology , Neurons/physiology , Rats , Rats, Sprague-Dawley , Receptor, Serotonin, 5-HT1B , Receptor, Serotonin, 5-HT1D , Receptors, Serotonin/drug effects , Trigeminal Nuclei/cytology , Trigeminal Nuclei/physiology , Vibrissae/drug effects , Vibrissae/innervation
4.
Eur J Pharmacol ; 362(1): 43-6, 1998 Nov 27.
Article in English | MEDLINE | ID: mdl-9865528

ABSTRACT

Pre-clinical studies have suggested that one mechanism of antimigraine action of the 'triptan' 5-HT1B/1D receptor agonists may be through inhibition of central nociceptive transmission in the trigeminal dorsal horn. In anaesthetized rats, the 5-HT1B/1D receptor agonist, zolmitriptan (up to 3 mg kg(-1), i.v.), inhibited the action potential discharge of single trigeminal neurones to noxious electrical stimulation of the middle meningeal artery. In contrast, the selective 5-HT1B receptor agonist, CP-93,129 (3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one), and the 5-HT1A receptor selective agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) had no effect in this assay at up to 3 mg kg(-1), i.v.. Brain penetrant, triptan 5-HT1B/1D receptor agonists may therefore mediate their central trigeminal anti-nociceptive action in the rat via 5-HT1D, but not 5-HT1B or 5-HT1A, receptors.


Subject(s)
Oxazoles/pharmacology , Oxazolidinones , Receptors, Serotonin/drug effects , Serotonin Receptor Agonists/pharmacology , Trigeminal Caudal Nucleus/drug effects , 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology , Action Potentials/drug effects , Analgesics/pharmacology , Animals , Electric Stimulation , Male , Migraine Disorders/drug therapy , Pyridines/pharmacology , Pyrroles/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Serotonin/classification , Tryptamines
5.
Cephalalgia ; 18(10): 659-63, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9950621

ABSTRACT

In vivo electrophysiological assays in anesthetized rats have been used to compare the effects of the 5HT1B/1D receptor agonist, naratriptan, on central trigeminal nociceptive processing from dural and cutaneous inputs with its effects on nociceptive processing in the spinal cord. Naratriptan inhibited responses of single trigeminal neurons, to noxious electrical and mechanical stimulation of the dura and face, dose dependently by a maximum of 67+/-3% and 70+/-18%, respectively, at 3 mg kg(-1) i.v. In contrast, naratriptan did not affect spinal dorsal horn neuronal responses to noxious mechanical stimulation of the hind-paw. These findings suggest that 5HT1B/1D receptors have differential effects on nociceptive processing in the trigeminal versus spinal dorsal horns and provide a potential explanation for the lack of general analgesic effects of brain penetrant 5HT(1B/1D) agonist antimigraine drugs.


Subject(s)
Indoles/pharmacology , Piperidines/pharmacology , Serotonin Receptor Agonists/pharmacology , Spinal Cord/drug effects , Trigeminal Nerve/drug effects , Animals , Drug Evaluation, Preclinical , Dura Mater/drug effects , Electric Stimulation , Male , Rats , Rats, Sprague-Dawley , Stress, Mechanical , Tryptamines
6.
Neuropharmacology ; 37(12): 1535-43, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9886676

ABSTRACT

In adult rats response latencies to innocuous mechanical stimuli were found to be reduced and, in electrophysiological studies, the receptive fields of dorsal horn neurones were enlarged 7-14 days after chronic constriction injury of the sciatic nerve. The NK1 receptor antagonist GR205171 at 3 mg kg(-1) blocked responses to NK1 agonist evoked activity and reversed the mechanical hypersensitivity following nerve ligation in behavioural assays. GR205171 also reversed the receptive field expansion of spinal dorsal horn neurones caused by loose ligation of the sciatic nerve in an electrophysiological assay in anaesthetised rats. The less active enantiomer L-796,325 did not block NK1 agonist evoked activity at up to 10 mg kg(-1) and had no effect on behavioural or electrophysiological changes following nerve injury, indicating that the effects of GR205171 were attributable to selective NK1 receptor blockade. These data suggest that NK1 receptor antagonists may be useful for the treatment of certain types of neuropathic pain.


Subject(s)
Neurokinin-1 Receptor Antagonists , Neurons/physiology , Pain/physiopathology , Peripheral Nervous System Diseases/physiopathology , Piperidines/pharmacology , Sciatic Nerve/physiology , Spinal Cord/physiology , Tetrazoles/pharmacology , Analysis of Variance , Animals , Functional Laterality , Hyperalgesia/physiopathology , Isomerism , Male , Mice , Neurons/drug effects , Peripheral Nervous System Diseases/drug therapy , Rats , Rats, Sprague-Dawley , Sciatic Nerve/drug effects , Sciatic Nerve/physiopathology , Spinal Cord/drug effects , Spinal Cord/physiopathology
7.
Neuroscience ; 80(1): 251-65, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9252236

ABSTRACT

The importance of receptors for N-methyl-D-aspartate in synaptic plasticity and in triggering long-term pronociceptive changes is explained by their voltage-dependence. This suggests that their contribution to acute nociceptive responses would be determined both by the magnitude of synaptic input and by the level of background excitation. We have now examined the role of N-methyl-D-aspartate receptors in acute nociceptive transmission in the spinal cord. Drugs selectively affecting activity mediated by these receptors were tested on responses of dorsal horn neurons to noxious stimuli of different intensities and at different levels of ongoing spike discharge. The drugs used were the N-methyl-D-aspartate receptor channel blocker ketamine; the competitive antagonists, 3-((R)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (D-CPP) and D-2-amino-5-phosphonopentanoic acid (D-AP5), and the positive modulator thyrotropin-releasing hormone. The activity of dorsal horn wide dynamic range neurons was recorded extracellularly in alpha-chloralose-anaesthetized spinalized rats. Their responses to noxious stimuli (pinch, heat and electrical) were monitored in parallel with responses to iontophoretic N-methyl-D-aspartate and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA). Drugs were given i.v. or (D-AP5) iontophoretically. At doses that selectively inhibited responses to exogenous N-methyl-D-aspartate, ketamine (4 or 8, mean 5 mg/kg i.v.) reduced the nociceptive responses of the majority of the cells in deep dorsal horn. Ketamine also reduced wind-up of the responses to repetitive electrical stimulation. Ketamine (4 or 8 mg/kg). D-CPP (2 mg/kg), D-AP5 (iontophoretically) and thyrotrophin-releasing hormone (1 mg/kg) were tested on different magnitude nociceptive responses evoked by alternating intensities of noxious heat or pinch. In percentage terms, the less vigorous responses were affected by all four drugs as much as or more than the more vigorous responses. When background activity of neurones was enhanced by continuous activation of C-fibres with cutaneous application of mustard oil, ketamine was less effective against superimposed noxious pinch responses. Ongoing background activity was affected in parallel with evoked responses. When background discharge of the cells was maintained at a stable level with continuous ejection of kainate, neither the N-methyl-D-aspartate antagonists nor thyrotrophin-relasing hormone affected the responses to noxious pinch or heat, although responses to exogenous N-methyl-D-aspartate were still blocked. The wind-up of the electrical responses was, however, reduced by ketamine irrespective of the level of background activity. The results indicate that under these conditions in vivo, N-methyl-D-aspartate receptors mediate ongoing low-frequency background activity rather than phasic high-frequency nociceptive responses. The effects of N-methyl-D-aspartate antagonists and positive modulators on nociceptive responses are evidently indirect, being secondary to changes in background synaptic excitation. These results cannot be explained simply in relation to the voltage-dependence of N-methyl-D-aspartate receptor-mediated activity; other factors, such as modulation by neuropeptides, must be involved.


Subject(s)
Nociceptors/drug effects , Receptors, N-Methyl-D-Aspartate/physiology , Spinal Cord/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Excitatory Amino Acid Antagonists/pharmacology , Ketamine/pharmacology , Male , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/drug effects , Spinal Cord/drug effects
8.
Eur J Pharmacol ; 328(1): 37-40, 1997 Jun 05.
Article in English | MEDLINE | ID: mdl-9203565

ABSTRACT

The 5-HT(1B/1D) receptor agonist rizatriptan constricts intracranial, extracerebral blood vessels, inhibits neurogenic vasodilation and extravasation in the meninges and is effective clinically against migraine. The present study has investigated whether rizatriptan may also have activity at 5-HT(1B/1D) receptors within the central nervous system (CNS) that contributes to its antimigraine effects. Action potentials evoked by electrical stimulation of the dura-mater were recorded extracellularly from single neurones in the trigeminal nucleus caudalis in anaesthetized rats. Rizatriptan dose dependently inhibited these nociceptive dural responses by up to 63 +/- 9% after 3 mg/kg, i.v. Rizatriptan therefore has central activity which may contribute to its efficacy against migraine headache.


Subject(s)
Action Potentials/drug effects , Pain/drug therapy , Serotonin Receptor Agonists/pharmacology , Triazoles/pharmacology , Trigeminal Caudal Nucleus/drug effects , Analysis of Variance , Animals , Blood-Brain Barrier/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Dura Mater/drug effects , Dura Mater/physiology , Electric Stimulation , Electrophysiology , Injections, Intravenous , Male , Microelectrodes , Migraine Disorders/drug therapy , Neurons/drug effects , Neurons/physiology , Rats , Rats, Sprague-Dawley , Serotonin Receptor Agonists/administration & dosage , Serotonin Receptor Agonists/therapeutic use , Triazoles/administration & dosage , Triazoles/therapeutic use , Trigeminal Caudal Nucleus/cytology , Trigeminal Caudal Nucleus/metabolism , Tryptamines
9.
Neurosci Lett ; 204(1-2): 33-6, 1996 Feb 02.
Article in English | MEDLINE | ID: mdl-8929971

ABSTRACT

The (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate receptor antagonists 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline (NBQX) and 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX) were examined by microiontophoretic administration in electrophysiological tests on spinal neurones in alpha-chloralose anaesthetized rats. The antagonists significantly reduced extracellularly recorded nociceptive and non-nociceptive responses, as expected; concurrently they reduced background discharge. When the background discharge rate was held constant, the antagonists no longer significantly reduced the evoked responses. This indicates that in the absence of such control, the antagonists decreased cell excitability and only indirectly affected the test responses. Unless such indirect effects have been controlled for, the interpretation of the actions of AMPA/kainate antagonists on evoked synaptic responses is compromised and may be erroneous.


Subject(s)
Neurons, Afferent/physiology , Receptors, AMPA/antagonists & inhibitors , Receptors, Kainic Acid/antagonists & inhibitors , Spinal Cord/physiology , Synaptic Transmission/physiology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Evoked Potentials/drug effects , Evoked Potentials/physiology , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Extracellular Space/drug effects , Extracellular Space/physiology , Iontophoresis , Male , Microelectrodes , N-Methylaspartate/pharmacology , Nociceptors/drug effects , Nociceptors/physiology , Quinoxalines/pharmacology , Rats , Rats, Wistar , Spinal Cord/cytology
10.
Br J Pharmacol ; 115(6): 1005-12, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7582496

ABSTRACT

1. The effects of tachykinins and agonists selective for the three subtypes of neurokinin (NK) receptor have been tested on spinal neuronal responses both to the excitatory amino acids (EAAs) NMDA, AMPA and kainate, and to noxious heat stimuli. The agonists were applied by microiontophoresis in in vivo experiments in alpha-chloralose-anaesthetized, spinalized rats. 2. The NK1-selective agonist, GR 73632, enhanced responses to all three EAAs similarly, whilst the NK2-selective agonist, GR64349, reduced responses to AMPA and kainate without affecting those to NMDA, and the NK3 selective agonist, senktide, enhanced responses to AMPA and kainate. 3. The endogenous ligands substance P (SP) and neurokinin A (NKA) both enhanced responses to NMDA with little effect on responses to kainate, whereas neurokinin B (NKB) selectively enhanced responses to kainate without affecting those to NMDA. 4. The effects of GR73632 on EAA responses showed some differences between the dorsal and ventral horn, with more selectivity towards enhancement of NMDA responses in the ventral horn, but a smaller maximum effect. 5. Background activity was significantly enhanced by GR73632, GR64349, SP and NKA but not by senktide or NKB. GR73632 had the greatest effect on background firing, but this action was variable between cells and was related both to the location within the spinal cord and to the degree of spontaneous activity prior to GR73632 administration. 6. Responses to noxious heat were enhanced consistently only by NKA. 7. These data show that selective agonists for the tachykinin receptors are capable of modulating EAA responses differentially. SP, NKA and NKB appear to act via more than one receptor type when modulating EAA responses in vivo. This indicates that NK-EAA interactions can be more specific than suggested hitherto, with the combined actions at NKI and NK2 receptors biasing EAA responsiveness towards NMDA receptor mediated functions, whereas NK3 receptor activation would have the opposite effect. The physiological role of such interactions is likely to be complex.


Subject(s)
Excitatory Amino Acids/metabolism , Receptors, Neurokinin-1/drug effects , Receptors, Tachykinin/agonists , Receptors, Tachykinin/drug effects , Spinal Cord/drug effects , Tachykinins/pharmacology , Animals , Electrophysiology , Male , N-Methylaspartate/metabolism , Peptide Fragments/pharmacology , Rats , Rats, Inbred Strains , Receptors, Neurokinin-1/classification , Substance P/analogs & derivatives , Substance P/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
11.
Br J Pharmacol ; 115(6): 1013-9, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7582497

ABSTRACT

1. The effects of selective tachykinin (neurokinin, NK) NK1 and NK2 receptor antagonists have been examined on spinal neurones in alpha-chloralose anaesthetized, spinalized rats. They were tested for effects on responses both to excitatory amino acids (EAA) and to noxious heat stimuli. They were also tested for their ability to reverse the actions of selective NK agonists. 2. The NK1-selective antagonists GR82334 (peptide) and CP-99,994 (non-peptide), when applied by microiontophoresis, both reduced responses to kainate > AMPA > NMDA. Intravenous CP-99,994 (3 mg kg-1) also reduced responses to kainate but had inconsistent effects on nociceptive responses. 3. GR82334, applied microiontophoretically, reduced the enhancement by the selective NK1 agonist, GR73632 of both responses to EAAs and background activity. Systemic CP-99,994 (< or = 10 mg kg-1) failed to reverse the effects of GR73632. 4. The selective peptide NK2 antagonist, GR103537, had no consistent effects on responses to EAAs when applied by iontophoresis. In contrast, the non-peptide NK2 antagonist, GR159897, administered systemically (0.5-2 mg kg-1, i.v.) enhanced responses to kainate (but not NMDA); responses to noxious heat were enhanced only weakly. 5. Iontophoretically-administered GR103537 attenuated the effects of the NK2 agonist GR64349, which selectively reduced responses to kainate compared to those to NMDA. Systemically administered GR159897 (< or = 2 mg kg-1, i.v.) caused little antagonism of the effects of GR64349. 6. The data indicate that under these conditions the non-peptide antagonists are not reliable at reversing the actions of selective NK agonists. 7. These results suggest that there is a tonic release of endogenous tachykinins that can modulate glutamatergic neurotransmission in the spinal cord. They provide further support for the hypothesis that release of endogenous NKs acting on NK1 and NK2 receptors can promote NMDA receptor mediated glutamatergic transmission.


Subject(s)
Excitatory Amino Acids/metabolism , Neurokinin-1 Receptor Antagonists , Receptors, Neurokinin-1/drug effects , Receptors, Neurokinin-2/antagonists & inhibitors , Receptors, Neurokinin-2/drug effects , Spinal Cord/drug effects , Animals , Dose-Response Relationship, Drug , Male , Physalaemin/analogs & derivatives , Physalaemin/pharmacology , Piperidines/pharmacology , Rats , Rats, Inbred Strains , Spinal Cord/metabolism
12.
Neurosci Lett ; 181(1-2): 98-102, 1994 Nov 07.
Article in English | MEDLINE | ID: mdl-7534894

ABSTRACT

The ability of excitatory amino acids (EAAs) to modulate nociceptive and non-nociceptive responses was tested on spinal neurones of the anaesthetized rat. NMDA (N-methyl-D-aspartate), AMPA ((RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate) and kainate were applied by iontophoretic ejection to increase the background firing rate of each cell to approximately 25 spikes/s. Responses to noxious heat and pinch and innocuous tap stimuli were enhanced to similar degrees by all three EAAs and returned to control immediately following termination of EAA ejection. This result shows that, whilst NMDA does enhance synaptic responses of spinal neurones, this effect is little or no greater than for AMPA or kainate. Furthermore, the rapid recovery of nociceptive responses indicates that more than NMDA receptor activation alone is required to induce longer-term enhancement of nociceptive responses (hyperalgesia).


Subject(s)
Kainic Acid/pharmacology , N-Methylaspartate/pharmacology , Neurons/drug effects , Pain/physiopathology , Spinal Cord/drug effects , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology , Animals , Electrophysiology , Hot Temperature , Male , Neurons/physiology , Nociceptors/drug effects , Physical Stimulation , Rats , Rats, Wistar , Spinal Cord/pathology , Spinal Cord/physiopathology , Time Factors
13.
Br J Pharmacol ; 112(3): 843-6, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7522860

ABSTRACT

1. The effects of intravenous administration of two alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonists were studied on responses of single neurones to iontophoretically applied excitatory amino acids. The tests were performed on spinal neurones in alpha-chloralose anaesthetized, spinalized rats. 2. Both the quinoxaline, NBQX (2-16 mg kg-1) and the 2,3-benzodiazepine, GYKI 53655 (2-8 mg kg-1) dose-dependently decreased responses to AMPA. 3. Both compounds were short acting, with half-recovery times of 15 min for NBQX and 7 min for GYKI 53655. 4. The selectivity for responses to AMPA over those to N-methyl-D-aspartate (NMDA) was significantly poorer for systemic NBQX than for either systemic GYKI 53655 or iontophoretic NBQX, suggesting that systemic NBQX may be converted to a less selective metabolite. 5. GYKI 53655 is therefore likely to be a more valuable tool than NBQX for the study of AMPA receptor-mediated processes in vivo.


Subject(s)
Benzodiazepines/pharmacology , Quinoxalines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Spinal Cord/drug effects , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/antagonists & inhibitors , Animals , Benzodiazepines/administration & dosage , Hot Temperature , Injections, Intravenous , Iontophoresis , Male , N-Methylaspartate/antagonists & inhibitors , Neurons/drug effects , Quinoxalines/administration & dosage , Rats , Rats, Wistar , Spinal Cord/cytology
14.
Neuroreport ; 5(8): 877-80, 1994 Apr 14.
Article in English | MEDLINE | ID: mdl-7520299

ABSTRACT

The relative roles of receptors for AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) in spinal nociceptive and non-nociceptive transmission were studied on dorsal horn wide dynamic range neurones in alpha-chloralose-anaesthetized spinalized rats. The effects of systemically administered competitive and non-competitive AMPA antagonists (the quinoxalinedione NBQX and the 2,3-benzodiazepine GYKI 53655) were examined on responses to peripheral noxious heat and non-noxious tap stimuli as well as to iontophoretic AMPA and N-methyl-D-aspartate (NMDA). Both NBQX and GYKI 53655 dose-dependently reduced responses to peripheral stimuli and to AMPA. GYKI 53655, the more selective antagonist of AMPA vs NMDA, decreased heat and tap responses to the same extent. The results indicate that AMPA receptors play a significant and equal, but not exclusive, role in mediating nociceptive and non-nociceptive spinal transmission.


Subject(s)
Nociceptors/physiology , Receptors, AMPA/physiology , Spinal Cord/physiology , Synaptic Transmission/physiology , Action Potentials/drug effects , Animals , Benzodiazepines/pharmacology , Dose-Response Relationship, Drug , Iontophoresis , Male , N-Methylaspartate/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar , Receptors, AMPA/antagonists & inhibitors , Synapses/drug effects , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL